483
Pharmaceutical Specialties, Inc.Pharmaceutical Specialties, Inc. – FDA 483, May 3, 2019
Record Details
An FDA inspection of Pharmaceutical Specialties, Inc. in Rochester, MN, a manufacturer of OTC drug products, revealed significant deficiencies in their quality control systems. Observations included a lack of written procedures and process validation for drug product manufacturing, as well as inadequate cleaning validation for equipment. Furthermore, the firm's Quality Unit failed to reject a subpotent batch of Vanicream™ Sunscreen, leading to its release and distribution.
- Person
View Company Profile
ID · 4eea6d7a-e4d5-4e11-845f-3031e5075c16
Other documents for Pharmaceutical Specialties, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.